A modern clinic for at-home treatments
(857) 240-1080
! Not medical advice. Consult a doctor.







Mepolizumab, marketed under the brand name Nucala, is a therapeutic agent used in the management of specific inflammatory conditions, and it falls under the category of monoclonal antibodies. This medication is specifically designed to target and inhibit interleukin-5 (IL-5), a cytokine involved in the inflammatory pathway of certain diseases.
Drug Category
Mepolizumab is classified as an anti-interleukin-5 monoclonal antibody. This category of drugs is designed to neutralize the action of IL-5, thereby reducing eosinophilic inflammation, which is a hallmark in several conditions.
Indications
This medication is primarily indicated for use in the treatment of severe eosinophilic asthma, a form of asthma characterized by elevated levels of eosinophils, a type of white blood cell. These cells play a crucial role in the inflammatory processes that exacerbate asthma symptoms.
Conditions Treated
Mepolizumab’s mechanism of action significantly aids in controlling symptoms and reducing exacerbations in these conditions, providing therapeutic benefits to individuals with challenging eosinophil-associated diseases.
Why settle for temporary relief? Try immunotherapy for lasting results!
Am I eligible?
Mepolizumab, marketed as Nucala, is used to treat certain conditions that involve eosinophils, a type of white blood cell that can contribute to inflammation and damage in various parts of the body.
Severe Eosinophilic Asthma
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Hypereosinophilic Syndrome (HES)
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Find out if immunotherapy is right for you

Mepolizumab (Nucala) is a biologic medication used primarily for the treatment of severe eosinophilic asthma, among other conditions. Its targeted mechanism offers several benefits to patients who suffer from this type of asthma and related ailments.
Targeted Therapy
Improved Asthma Control
Convenience and Adherence
Wide Range of Application
Patient-Centered Outcomes

Mepolizumab, marketed as Nucala, is a medication used primarily for the treatment of severe eosinophilic asthma and other conditions caused by high levels of eosinophils. While effective, it does come with potential side effects and necessitates certain safety precautions.
Possible Side Effects of Mepolizumab (Nucala)
Safety Precautions When Using Mepolizumab (Nucala)
A safer solution to allergies: try immunotherapy today!

When considering the treatment of allergies, it is important to evaluate the advantages of immunotherapy over medications such as Mepolizumab (Nucala). Immunotherapy offers a more comprehensive approach to addressing the root cause of allergies compared to symptomatic relief offered by medications.
Addresses Root Cause
Wide Range of Allergies
Sustainability and Cost-Effectiveness
Few Side Effects
Improvement in Quality of Life

Treatment prescribed
by clinician


Clinicaly made allergen extracts are customized for your allergies


Your immune system gets desensitized to allergens, giving you long-term relief.
Medical disclaimer.
This page is for educational purposes only and is not medical advice, diagnosis, or treatment. It is not a substitute for consultation with a licensed healthcare provider. Always talk to a qualified clinician before starting, stopping, or changing any allergy treatment. Outcomes from allergy immunotherapy vary from patient to patient. Response rates, symptom-reduction percentages, timelines, and pricing referenced on this page are based on peer-reviewed literature, clinical guidelines, and current Curex membership plans at the time of review - they are population averages or current offers, not a prediction of individual results, and are subject to change. Eligibility for any treatment is determined by a licensed clinician on a case-by-case basis. Cntent reviewed by a licensed clinician. References to third-party products, brand names, or competitor services are for educational comparison only and do not imply endorsement.